# A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy Participants

> **NCT06511973** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 42 (actual)

## Conditions studied

- Pain
- Healthy Volunteers

## Interventions

- **DRUG:** Naproxen (BAYH006689)
- **DRUG:** Placebo Gel
- **DRUG:** A solution of 0.9% Saline
- **DRUG:** A solution of 0.2% SLS

## Key facts

- **NCT ID:** NCT06511973
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-23
- **Primary completion:** 2024-08-20
- **Final completion:** 2024-08-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511973, "A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy Participants". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06511973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*